期刊文献+

同安区居民癌症负担中早死所致生命损失分析 被引量:1

AN ANALYSIS ON LIFE LOST WITH PREMATURE DEATH OUT OF THE CANCER BURDEN OF RESIDENTS IN TONG AN COUNTY.
下载PDF
导出
摘要 目的 :了解 1990~ 2 0 0 1年同安区居民癌症负担中因早死所致生命损失。方法 :采用世界银行全球疾病负担评价指标体系和 1990~ 2 0 0 1年同安区死亡登记报告资料 ,分析恶性肿瘤给同安区居民健康造成的损失。结果 :肝癌、食管癌、胃癌因早死所致生命损失年 (YL LS)占恶性肿瘤总 YL LS76 .5 6 %。其中 ,肝癌在恶性肿瘤 YL LS顺位中位居第一。肺癌 YL LS呈上升趋势。因早死所致生命损失主要发生在 30~ 74岁年龄组人群。结论 :消化道恶性肿瘤 ,尤其肝癌是危害该区居民生命健康的主要恶性肿瘤。 Objective:To study years of life lost with premature death out of the cancer burden of residents in Tong'an county,Fujian province from 1990 to 2001.Methods:Employ the index system of the globe burden of disease that comes from the World Bank and the data of death register in Tong'an from 1990 to 2001 to analyze health lost of residents in Tong'an induced by malignant tumors.Results:YLL S (Years of Life Lost with Premature Death) of liver cancer,esophageal cancer and stomach cancer occupy 75.56% of the sum of YLL S of malignant tumors.Among them,liver cancer takes the first in the sequence of YLL S of malignant tumors.And YLL S of lung cancer has the trend of ascent.Life lost with premature death mainly happen in age group of 30 to 74.Conclusions:Digestive tract malignant tumors,particular liver cancer,are the main malignant tumors that endanger residents' health in Tong'an county.
出处 《现代预防医学》 CAS 2004年第3期326-327,340,共3页 Modern Preventive Medicine
基金 全国优秀博士学位论文作者专项资金 ( 2 0 0 15 7)
关键词 同安区 居民 癌症 疾病负担 死亡 Cancer Disease burden DALY(Disability Adjusted Life Year)
  • 相关文献

参考文献3

  • 1Murray CJL. Quantifying the burden of disease: technical basis for disability- adjusted life years [A] . Bulletin of the World Health Organization, 1994, 72 (3): 429-445.
  • 2Murray CJL, Lopez AD. Quantifying disability: data. methods and results [A] . Bulletin of the World Health Organization, 1994, 72 (3): 481-494.
  • 3Kendall MG.Time Series[M].London:Griffin Co.Ltd,1973.

同被引文献40

  • 1孙建东,郭晓雷,李维卡,张吉玉,付振涛,鹿子龙,徐爱强,王涛,李卫.山东省恶性肿瘤疾病负担研究[J].中国卫生经济,2007,26(8):64-66. 被引量:41
  • 2Gravalos C,Jimeno A.HER2in gastric cancer:a new prognostic factor and a novel therapeutic target[J].Ann Oncol,2008,19(9):1 523.
  • 3Garnock-Jones KP,Keating GM,Scott LJ.Trastuzumab:a review of its use as adjuvant treatment in human epidermal growth factor receptor2(HER2)-positive early breast cancer[J].Drugs,2010,70(2):215.
  • 4Dai GH,Shi Y,Chen L,et al.Trastuzumab combined with docetaxel-based regimens in previously treated metastatic gastric cancer patients with HER2over-expression[J].Hepatogastroenterology,2012,59(120):2 439.
  • 5Cortés-Funes H,Rivera F,Alés I,et al.PhaseⅡstudy of trastuzumab and cisplatin in patients with advanced gastric cancer(AGC)with HER2/neu overexpression/amplification[J].J Clin Oncol,2007,25(18):4 613.
  • 6Grávalos C,Gómez-Martín C,Rivera F,et al.PhaseⅡstudy of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer[J].Clin Transl Oncol,2011,13(3):179.
  • 7Qiu MZ,Li Q,Wang ZQ,et al.HER2-positive patients receiving trastuzumab treatment have acomparable prognosis with HER2-negative advanced gastric cancer patients:a prospective cohort observation[J].Int J Cancer,2014,134(10):2 468.
  • 8Egamberdiev DM,Djuraev MD,Tuydjanova K,et al.Our experience in the use of trastuzumab in patients with advanced stomach cancer[J].Ann Oncol,2010,21(Suppl8):839.
  • 9Bang YJ,Van Cutsem E,Feyereislova A,et al.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer(To GA):a phase3,open-label,randomised controlled trial[J].Lancet,2010,376(9 742):687.
  • 10Hegewisch-Becker S,Moorahrend E,Kr?ning H,et al.Trastuzumab(TRA)in combination with different first-line chemotherapies for treatment of HER2-positive metastatic gastric or gastroesophageal junction cancer(MGC):findings from the German noninterventional observational study hermes:2012ASCO Annual Meeting Abstracts[J].J Clin Oncol,2012,30(Suppl15):4 065.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部